Lead Product(s) : Malic Acid
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : University of Lisbon | Portuguese Institute of Rheumatology | Dentaid
Deal Size : Inapplicable
Deal Type : Inapplicable
Quality of Life and Sjögren Syndrome
Details : Malic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Xerostomia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 06, 2018
Lead Product(s) : Malic Acid
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : University of Lisbon | Portuguese Institute of Rheumatology | Dentaid
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
